Spire Wealth Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Spire Wealth Management’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.16K	Hold	206	–	–	﹤0.01%	1855
2026 Q1	$4.04K	Sell	206 -7	-3%	-$171	﹤0.01%	1888
2025 Q4	$5.7K	Sell	213 -4	-2%	-$103	﹤0.01%	1890
2025 Q3	$5.78K	Buy	217 +5	+2%	+$129	﹤0.01%	1923
2025 Q2	$4.87K	Hold	212	–	–	﹤0.01%	1956
2025 Q1	$6.15K	Buy	212 +10	+5%	+$319	﹤0.01%	2001
2024 Q4	$7.5K	Hold	202	–	–	﹤0.01%	1928
2024 Q3	$9.8K	Hold	202	–	–	﹤0.01%	1642
2024 Q2	$8.08K	Buy	+202	New	+$8.37K	﹤0.01%	1702
2024 Q1	–	Sell	-280	Closed	-$15.4K	–	2305
2023 Q4	$15.4K	Buy	+280	New	+$14.7K	﹤0.01%	1618
2023 Q3	–	Sell	-19,523	Closed	-$1.12M	–	2356
2023 Q2	$1.12M	Buy	+19,523	New	+$865K	0.04%	327

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Spire Wealth Management's AMPH Position: Q2 2026 in Review

Spire Wealth Management held its Amphastar Pharmaceuticals (AMPH) position steady in Q2 2026 at 206 shares worth $4.16K. The position accounts for ﹤0.01% of the portfolio, ranked #1855.

Spire Wealth Management first reported a position in AMPH in Q2 2023 and has held it in 11 quarters since. The position peaked at $1.12M in Q2 2023. 210 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

Spire Wealth Management held 206 shares of Amphastar Pharmaceuticals worth $4.16K as of Q2 2026.
Spire Wealth Management left its Amphastar Pharmaceuticals share count unchanged in Q2 2026.
Amphastar Pharmaceuticals made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1855 holding.
Spire Wealth Management first reported a position in Amphastar Pharmaceuticals in Q2 2023 and has held it in 11 quarters since.
Spire Wealth Management's Amphastar Pharmaceuticals position peaked at $1.12M in Q2 2023.
210 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.